Pay in 4 interest-free payments of $7.27 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Will Cole, DNM, IFMCP, DC is a leading functional medicine expert who consults people around the globe, starting one of the first functional medicine telehealth centers in the world
While semaglutide targets only GLP-1 receptors and tirzepatide targets GIP and GLP-1, Retatrutide adds glucagon receptor activity unlocking an additional fat-burning and energy-expenditure pathway that the others simply cannot match
placebo of 20.0 events per h in trial 1
Tirzepatide Tirzepatide acts as a dual GLP-1/GIP receptor agonist , with dosing starting at 2.5 mg weekly and titrating to 15 mg weekly
Media coverage overlap
US$ 29.05
US$ 29.95
US$ 26.93
US$ 28.62
